PhRMA spokesperson Chanse Jones acknowledged that coverage rejections and administrative hurdles by insurers delay and deny patient access to new treatments.

Drug pricing and affordability, FDA drug approvals, clinical trial design, drug shortages, insurer coverage, pharmaceutical regulation, and medication access.

Drug pricing policy, insurance prior authorization, and essential drug shortages affecting medication affordability and access.

Drug formulary design, coverage decisions, and insurer access policies.